Decisions guidelines? The guideline we have been discussing (or maybe I was discussing something different than what you are discussing) is the FDA AD draft development guidance. I am not aware of any "decisions guideline" that constitutes a strict rubric for the FDA to consider any AD therapy - where can I find that guidance?
Market Data 
Markets 
AI
